Yueyang Xingchang Petro-chemical News

Yueyang Xingchang (000819): Q3 revenue increased year-on-year, multiple new products opened up room for growth

Huaxin SecuritiesNov 7 00:00

Research Report Nuggets 丨 Guolian Securities: The Yueyang Xingchang Huizhou project will soon be put into operation, and the profit of MTBE, the main business, is expected to strengthen

Gelonghui FinanceJun 26, 2023 13:28

Yueyang Xing Chang (000819): The performance is in line with our expectations and the prospects for the rich metal polypropylene business are promising

國聯證券Apr 7, 2023 10:41

Yueyang Xingchang (000819) In-depth Research Report: Refining and Fine Chemical Leaders Focus on Specialty Polypropylene in the Short Term

國聯證券Oct 31, 2022 00:00

Yueyang Xingchang (000819): Q3 performance is in line with expectations, the first phase of the high-end polyolefin project will be put into operation next year

中郵證券Oct 27, 2022 00:00

Yueyang Xingchang (000819): High-end polyolefin project with performance in line with expectations to be put into operation next year

中郵證券Sep 16, 2022 00:00

[southwest Securities] Yueyang Xingchang: no, the main performance is reversed at the bottom.

西南證券Aug 26, 2015 00:00

Yueyang Xingchang (000819) comments on China News: no Ji Tailai's main performance reversal at the bottom

西南證券Aug 26, 2015 00:00

[Guoyuan Securities] Yueyang Xing Chang: Main business is improving, stomach disease vaccine program still needs to wait

國元證券Aug 18, 2010 00:00

[Huatai Securities] Yueyang Xingchang: Received “Oral Recombinant Helicobacter Pylori Vaccine” New Drug Certificate Review

華泰證券Apr 21, 2009 00:00

[Oriental Securities] Yueyang's rise: the road ahead is bright and tortuous

東方證券Mar 5, 2008 00:00

[Huatai Securities] Yueyang Xing: Breaking the Cocoon and Waiting Before Going Out

華泰證券Nov 6, 2007 00:00

[Citic Construction] S Yue Xingchang: the income may increase and the risk will gradually decrease.

中信建投證券Nov 29, 2006 00:00

[fortune Securities] S Yue Xingchang: stomach disease vaccine has a broad prospect or may become a biomedical company

財富證券Nov 10, 2006 00:00

[China Merchants] Yueyang Xingchang (000819): innovative Vaccine, Future profit doubles and value is undervalued

招商證券Oct 16, 2006 00:00

[Citic Construction Investment] Yueyang Xingchang: the development direction of the main business is gradually clear and the share reform is approaching.

中信建投證券Aug 22, 2006 00:00

【中信建投】岳阳兴长：风险投资进入收获期

中信建投證券May 22, 2006 00:00